本文選題：中藥提取物復方制劑 + 新城疫病毒�。� 參考：《西北農林科技大學》2017年碩士論文

【摘要】：鴿新城疫(newcastle disease,ND)又稱鴿瘟或鴿Ⅰ型副粘病毒(pigeon paramyxovirus type 1,PPMV-1),是由新城疫病毒(newcastle disease virus,NDV)引起的一種急性、熱性、敗血性和高度接觸性傳染病。為預防和治療該疾病的發(fā)生,大量使用抗生素和化學類藥物,導致耐藥性和藥物殘留問題的出現(xiàn)。而且隨著生態(tài)養(yǎng)殖和綠色食品等概念的提出,我國規(guī)定在飼料和食品中嚴禁使用獸醫(yī)臨床中抗生素類藥物和化學類藥物。中藥具有抗病毒作用效果好、毒副作用小和無耐藥性等優(yōu)點,不但能提高機體免疫力,還能促進生長,提高生產性能等。本研究在中獸醫(yī)藥理論指導下,以金銀花、黃芩、連翹、貫葉連翹等10余味中藥提取物進行中藥提取物復方制劑,研究中藥提取物復方制劑的抗病毒能力、免疫增強能力和質量控制標準。結果如下:1.中藥提取物復方制劑高劑量(含生藥2 g/mL)預防、治療組和中劑量(含生藥1 g/mL)預防、治療組的血凝效價顯著降低(P0.01),其中中藥提取物復方制劑中劑量組(含生藥1 g/m L)的效果顯著。2.中藥提取物復方制劑能夠提高NDV疫苗抗體效價,中藥提取物復方制劑中劑量組(含生藥1 g/mL)的抗體效價差異顯著(P0.05);中藥提取物復方制劑中劑量組法氏囊器官指數(shù)差異顯著(P0.05);免疫器官內淋巴細胞排列緊密,且淋巴細胞數(shù)量高于陽性對照組。3.以黃芩苷為檢測成分,利用TLC和HPLC檢測方法對中藥提取物復方制劑進行質量控制研究。TLC結果顯示,黃芩苷供試品和標準品在相應的位置上出現(xiàn)了顏色相同的斑點,陰性對照品中無干擾現(xiàn)象;HPLC結果顯示,黃芩苷在濃度為10~200μg/mL之間時線性關系良好,黃芩苷的含量為3727.41 mg/g,在供試品中的黃芩苷峰保留時間與標準品中的峰是一致的,且陰性對照品無干擾現(xiàn)象。中藥提取物復方制劑對新城疫病毒具有較好的抑制作用,能夠顯著提高NDV疫苗抗體效價和法氏囊器官指數(shù),免疫器官內淋巴細胞排列緊密且數(shù)量增多。所建立的黃芩苷TLC和HPLC檢測方法,專屬性強,可快速準確地對中藥提取物復方制劑中黃芩苷進行檢測。
[Abstract]:Pigeon Newcastle disease (NDV), also known as pigeon plague or pigeon paramyxovirus type 1 (PPMV-1), is an acute, feverish, septic and highly contagious disease caused by Newcastle disease virus. In order to prevent and treat the disease, antibiotics and chemical drugs are used extensively, which leads to the emergence of drug resistance and drug residues. With the concept of ecological breeding and green food being put forward, the use of antibiotics and chemical drugs in veterinary clinic is strictly prohibited in feed and food in China. Traditional Chinese medicine has the advantages of good antiviral effect, little side effect and no drug resistance. It can not only improve the body immunity, but also promote growth, improve the production performance and so on. In this study, under the guidance of Chinese veterinary medicine theory, 10 aftertaste extracts such as Flos Lonicerae, Radix Scutellariae, Forsythia Forsythia and Hypericum perforatum were used to prepare Chinese medicine extract compound preparation, and the antiviral ability of compound preparation of traditional Chinese medicine extract compound preparation was studied. Immune enhancement and quality control standards. The result is as follows: 1. High dose (including crude drug 2 g / mL) prevention, treatment group and middle dose (containing crude drug 1 g / mL) prevention, The hemagglutination titer of the treatment group was significantly lower than that of the control group, and the effect of the middle dose group (containing 1 g / m L crude drug) was significant. The compound preparation of Chinese traditional medicine extract can improve the antibody titer of NDV vaccine. The antibody titers of the middle dose group (containing 1 g / mL crude drug) were significantly different from those of the middle dose group (P 0.05), the difference of the bursa organ index was significant (P 0.05), and the lymphocytes in the immune organs were closely arranged. The number of lymphocytes was higher than that of positive control group. Using baicalin as the detection component, the quality control of compound preparation of traditional Chinese medicine extract was studied by TLC and HPLC. The results showed that the same color spots appeared in the samples and standard samples of baicalin. The results of HPLC showed that baicalin had a good linear relationship when the concentration of baicalin was 10 渭 g / mL, and the content of baicalin was 3727.41 mg / g. The retention time of baicalin peak in the sample was the same as that in the standard sample. And negative reference substance has no interference phenomenon. The compound preparation of Chinese traditional medicine extract has a good inhibitory effect on Newcastle disease virus, can significantly improve the antibody titer of NDV vaccine and the bursal organ index of bursa, and the lymphocyte arrangement in immune organs is close and the number of lymphocytes increases. The established TLC and HPLC methods for the detection of baicalin can be used for rapid and accurate determination of baicalin in compound preparations of traditional Chinese medicine.
【學位授予單位】：西北農林科技大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：S853.7

【參考文獻】

相關期刊論文 前10條

1 趙增成;林樹乾;李桂明;馮敏燕;黃中利;楊世發(fā);宋敏訓;傅劍;李穎;;白虎定喘口服液的質量檢測[J];動物醫(yī)學進展;2017年03期

2 郭炳陽;余永莉;駱士娟;尹小青;徐明振;;薄層色譜技術在桉葉油含藥血清制備中的應用[J];中國現(xiàn)代醫(yī)藥雜志;2017年01期

3 夏偉;董誠明;楊朝帆;陳浩;;連翹化學成分及其藥理學研究進展[J];中國現(xiàn)代中藥;2016年12期

4 張?zhí)戾a;史磊;劉雯;張美玲;楊建昕;李峰;;連翹化學成分、藥理活性現(xiàn)代研究[J];遼寧中醫(yī)藥大學學報;2016年12期

5 楊詹詹;魯?shù)劳?盧忠英;;傳統(tǒng)中藥金銀花的藥理作用研究進展[J];廣州化工;2016年20期

6 馬玲玲;孫燕;;中藥黃芩藥理作用的研究進展[J];沈陽醫(yī)學院學報;2016年02期

7 趙麗芬;韓省力;;高效液相色譜法測定雙黃連粉針劑中黃芩苷的含量[J];中醫(yī)藥信息;2015年06期

8 梁俊;黃良永;楊光義;;連翹配方顆粒高效液相色譜指紋圖譜[J];醫(yī)藥導報;2015年07期

9 謝景;馬生軍;辛博;王文全;侯俊玲;金燕清;閆彬彬;;黃芩有效成分與藥材粉末顏色的相關性研究[J];現(xiàn)代中藥研究與實踐;2015年03期

10 孫佳瑋;戴素麗;李磊;顏晰;張超;趙連梅;單保恩;;連翹根提取物(FSEER)對化療后小鼠骨髓和免疫抑制的影響[J];中國免疫學雜志;2015年05期

相關碩士學位論文 前4條

1 趙玉蓮;連翹酯苷對雞法氏囊炎癥因子及抗氧化功能的影響[D];東北農業(yè)大學;2013年

2 王紅梅;連翹酯苷對擬AD動物模型學習記憶的改善作用及其機制的研究[D];北京協(xié)和醫(yī)學院;2012年

3 陶鴿;中藥復方制劑對雞腎型傳染性支氣管炎的防治研究[D];揚州大學;2011年

4 趙炳凱;連芩口服液抗鴿Ⅰ型副粘病毒藥效及黃芩苷代謝動力學測定[D];南京農業(yè)大學;2009年

，

本文編號：2036787